Filing Details

Accession Number:
0001209191-15-050904
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-06-08 13:19:44
Reporting Period:
2015-05-20
Filing Date:
2015-06-08
Accepted Time:
2015-06-08 13:19:44
Original Submission Date:
2015-05-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1469443 Arcadia Biosciences Inc. RKDA Agricultural Chemicals (2870) 810571538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1536904 Dominic Redfern C/O Gfin Corporate Services Ltd.
9Th Floor, Orange Tower
Cybercity, Ebene O4
No No Yes No
1591836 Fund Agribusiness Mandala C/O Gfin Corporate Services Ltd.
9Th Floor, Orange Tower
Cybercity, Ebene O4
No No Yes No
1642120 Mandala Agribusiness Co-Investments I Ltd C/O Gfin Corporate Services Ltd.
9Th Floor, Orange Tower
Cybercity, Ebene O4
No No Yes No
1642124 Tej Gujadhur C/O Gfin Corporate Services Ltd.
9Th Floor, Orange Tower
Cybercity, Ebene O4
No No Yes No
1642125 Sheokumar Gujadhur C/O Gfin Corporate Services Ltd.
9Th Floor, Orange Tower
Cybercity, Ebene O4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-20 8,705,808 $0.00 8,705,808 No 4 C Direct
Common Stock Acquisiton 2015-05-20 375,000 $8.00 9,080,808 No 4 P Indirect By Mandala Capital AG Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Indirect By Mandala Capital AG Limited
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series D Convertible Preferred Stock Disposition 2015-05-20 8,918,750 $0.00 8,705,808 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The Series D Preferred Stock converted into Arcadia Biosciences, Inc. common stock on a conversion ratio of one share of common stock for approximately every 1.0245 shares of preferred stock upon the closing of the issuer's initial public offering of common stock, and had no expiration date. The conversion ratio reflected an adjustment due to the issuer's 1-for-4 reverse stock split effected on May 8, 2015.
  2. The Series D preferred stock which converted into Arcadia Biosciences, Inc. common stock is held by Mandala Agribusiness Co-Investments I Limited.
  3. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur are members of the board of Mandala Agribusiness Fund, which exercises shared voting and investment power over the shares owned by Mandala Agribusiness Co-Investments I Limited and also the shares owned by Mandala Capital AG Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur disclaim beneficial ownership of all securities listed herein, except to the extent of their respective pecuniary interests therein.